GleamWall
中文EN

PIII P3 Health Partners Inc.

Services-Health Services · Nasdaq · SEC CIK 1832511 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY7.5%
TTM net income YoY60.9%
TTM EPS YoY47.3%
Revenue 3-yr CAGR9.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-5.2%
Net margin-3.3%
FCF margin—
EBITDA margin0.2%

Returns

ROE-115.7%
ROA-7.6%
ROIC (approx.)-33.7%
Asset turnover2.30x

Leverage & solvency

Liabilities / assets70.0%
Debt / equity1.14x
Current ratio0.53x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.26x
Accruals ratio9.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312024Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$396.34M$386.38M$386.39M$384.81M$345.25M$355.79M$373.23M$370.69M
SG&A expense$34.27M$32.39M$25.54M$35.88M$22.39M$23.45M$25.00M$31.37M
Operating income$22.98M$41.23M$8.24M-$153.87M-$44.22M-$34.12M-$38.09M-$138.50M
Pretax income$30.80M$16.92M-$7.96M-$166.75M-$69.45M-$41.68M-$43.17M-$124.20M
Income tax$23,000$1.26M-$11.00M-$1.04M$11,000$1.98M$1.07M$4.95M
Net income$15.62M$7.44M$1.22M-$75.52M-$31.59M-$20.36M-$20.48M-$58.62M
EBITDA$44.02M$62.27M$29.31M-$132.87M-$23.19M-$13.04M-$17.04M-$117.35M
EPS (basic)0.13-0.630.37—-9.67-6.23-6.28—
EPS (diluted)0.07-0.630.32—-9.67-6.23-6.28—
Weighted avg. shares (diluted)6.63M3.36M8.42M—3.27M3.27M3.26M—
Banking
Net interest income-$5.04M-$7.86M-$16.77M-$15.64M-$20.53M-$10.14M-$8.72M-$6.83M
Balance sheet
Cash & equivalents$43.90M$21.27M$25.50M$25.01M$37.71M$38.58M$40.08M$44.10M
Current assets$216.03M$179.34M$172.21M$133.08M$135.63M$156.53M$191.44M$184.14M
PP&E, net$2.15M$2.53M$2.96M$3.37M$3.90M$4.69M$5.31M$5.73M
Intangibles$431.82M$452.40M$472.99M$492.42M$512.91M$533.40M$553.89M$574.35M
Total assets$669.72M$654.39M$674.16M$656.64M$683.56M$731.59M$783.87M$783.42M
Current liabilities$406.65M$388.58M$525.49M$545.26M$423.95M$505.00M$507.03M$496.42M
Short-term debt$84.43M$21.80M$51.44M$45.04M$38.61M$80.00M$65.00M$75.16M
Long-term debt$37.33M$98.05M$259.57M$228.37M$214.18M$101.96M$106.12M$108.91M
Total debt$121.76M$119.85M$311.00M$273.41M$252.79M$181.96M$171.12M$184.06M
Total liabilities$469.00M$516.75M$807.32M$796.88M$664.64M$644.41M$662.79M$633.89M
Shareholders' equity$107.27M$72.19M-$144.91M-$155.23M-$18.69M$44.46M$63.25M$75.94M
Net debt$77.86M$98.58M$285.51M$248.40M$215.08M$143.38M$131.04M$139.96M
Cash flow statement
Operating cash flow-$685,000-$61.91M-$27.47M-$25.73M-$15.41M-$16.63M-$33.47M-$57.24M
Capital expenditure———————$0
Free cash flow———————-$57.24M
Investing cash flow$0-$208,000-$43,000$198,000-$119,000$50,000$0-$475,000
Financing cash flow$24.29M$58.21M$27.80M$12.87M$14.67M$14.62M$30.66M$33.72M
Depreciation & amortization$21.04M$21.04M$21.07M$21.00M$21.03M$21.08M$21.05M$21.15M
Stock-based compensation-$421,000$866,000$1.05M$1.10M$1.21M$1.46M$1.81M$721,000

Free plan shows the latest 8 periods; Pro shows all 22 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.